Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF(V600E) mutation.
Tie J, Gibbs P, Lipton L, Christie M, Jorissen RN, Burgess AW, Croxford M, Jones I, Langland R, Kosmider S, McKay D, Bollag G, Nolop K, Sieber OM, Desai J.
Tie J, et al. Among authors: kosmider s.
Int J Cancer. 2011 May 1;128(9):2075-84. doi: 10.1002/ijc.25555.
Int J Cancer. 2011.
PMID: 20635392